17823-33-5

Basic information

• Product Name: Benzenesulfonamide, 3-(bromoacetyl)-
• CAS NO: 17823-33-5
• Molecular Formula: C8H8BrNO3S
• Molecular Weight: 278.126
• Mol File: 17823-33-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Benzenesulfonamide, 3-(bromoacetyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenesulfonamide, 3-(bromoacetyl)-(17823-33-5)
• EPA Substance Registry System: Benzenesulfonamide, 3-(bromoacetyl)-(17823-33-5)

Safety Data

• Hazardous Substances Data: 17823-33-5(Hazardous Substances Data)

Upstream product

• 99-03-6 1-(3-aminophenyl)ethanone 
• 35203-88-4 3-aminosulphonylacetophenone 

Downstream Products

• 1560633-73-9 3-{2-[2-(methylthio)-1H-benzimidazol-1-yl]acetyl}benzenesulfonamide 
• 1560633-65-9 3-[2-(2-isobutyl-1H-benzimidazol-1-yl)acetyl]benzenesulfonamide 
• 1560633-58-0 3-[2-(2-isopropyl-1H-benzimidazol-1-yl)acetyl]benzenesulfonamide 
• 1560633-51-3 3-[2-(2-butyl-1H-benzimidazol-1-yl)acetyl]benzenesulfonamide 
• 1560633-45-5 3-[2-(2-propyl-1H-benzimidazol-1-yl)acetyl]benzenesulfonamide 
• 1560633-38-6 3-[2-(2-ethyl-1H-benzimidazol-1-yl)acetyl]benzenesulfonamide 
• 1560633-32-0 3-[2-(2-benzyl-1H-benzimidazol-1-yl)acetyl]benzenesulfonamide 
• 1560633-25-1 3-{2-[2-(hydroxymethyl)-1H-benzimidazol-1-yl]acetyl}benzenesulfonamide 
• 1560633-17-1 3-[2-(2-methyl-1H-benzimidazol-1-yl)acetyl]benzenesulfonamide 
• 1560633-08-0 3-(2-(1H-benzimidazol-1-yl)acetyl)benzenesulfonamide 
• 85275-89-4 3-[1-Hydroxy-2-(1-methyl-3-phenyl-propylamino)-ethyl]-benzenesulfonamide; hydrochloride 
• 345947-67-3 3-{2-[Benzyl-(1-methyl-3-phenyl-propyl)-amino]-1-hydroxy-ethyl}-benzenesulfonamide 
• 345947-69-5 3-{2-[Benzyl-(1-methyl-3-phenyl-propyl)-amino]-acetyl}-benzenesulfonamide 

Relevant articles and documents

Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof

Benzenesulphonamide compounds of general formula (I), wherein R1is a hydrogen or halogen atom such as chlorine or fluorine, or a straight or branched C1-4alkyl or C1-4alkoxy group, each of R2, R3and R4, which are the same or different, is a hydrogen atom or a straight, branched or cyclic C1-4alkyl group, and R1is a hydrogen atom or a C1-2alkyl, C1-2fluoroalkyl or C1-2perfluoroalkyl group, in the form of enantiomers, diastereoisomers or mixtures thereof, including racemic mixtures, as well as pharmaceutically acceptable acid addition salts thereof, are provided for therapeutical use.